News Medical on MSN3d
NK cells with bispecific antibody yield high response rates in patients with lymphoma: Clinical trial
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Science Daily2d
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
Global NK Cell Therapy Clinical Trials FDA Approval Patent Market Size Report 2025
First NK Cell Therapy Approval Expected By 2028 Says Kuick Research In Its New Research Study On Global NK Cell Therapy ...
Yahoo Finance5d
Global NK Cell Therapy Clinical Trials FDA Approval Patent Market Size Report 2025
Research and development activities for NK cell therapies are rapidly evolving, backed by significant advancements in immunotherapy-centric cancer treatment approaches. Unlike other immune cells ...
Senti Bio Joins Webull Corporate Connect Service Platform
Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...
News Medical3d
Novel NK cell therapy shows strong response in lymphoma patients
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response ...